Literature DB >> 28082385

Management of Pregnancy in Patients With Complex Congenital Heart Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association.

Mary M Canobbio, Carole A Warnes, Jamil Aboulhosn, Heidi M Connolly, Amber Khanna, Brian J Koos, Seema Mital, Carl Rose, Candice Silversides, Karen Stout.   

Abstract

Today, most female children born with congenital heart disease will reach childbearing age. For many women with complex congenital heart disease, carrying a pregnancy carries a moderate to high risk for both the mother and her fetus. Many such women, however, do not have access to adult congenital heart disease tertiary centers with experienced reproductive programs. Therefore, it is important that all practitioners who will be managing these women have current information not only on preconception counseling and diagnostic evaluation to determine maternal and fetal risk but also on how to manage them once they are pregnant and when to refer them to a regional center with expertise in pregnancy management.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  AHA Scientific Statements; heart defects, congenital; heart diseases; pregnancy

Mesh:

Substances:

Year:  2017        PMID: 28082385     DOI: 10.1161/CIR.0000000000000458

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  53 in total

Review 1.  Maternal Stroke: an Update.

Authors:  Maria D Zambrano; Eliza C Miller
Journal:  Curr Atheroscler Rep       Date:  2019-06-22       Impact factor: 5.113

2.  Low-dose warfarin maternal anticoagulation and fetal warfarin syndrome.

Authors:  Ana R Sousa; Rita Barreira; Edmundo Santos
Journal:  BMJ Case Rep       Date:  2018-04-07

Review 3.  The Role of Cardiac Biomarkers in Pregnancy.

Authors:  Emily S Lau; Amy Sarma
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-07

4.  Contraceptive methods of privately insured US women with congenital heart defects.

Authors:  Kayla N Anderson; Naomi K Tepper; Karrie Downing; Elizabeth C Ailes; Ginnie Abarbanell; Sherry L Farr
Journal:  Am Heart J       Date:  2020-01-21       Impact factor: 4.749

Review 5.  Update on Valvular Heart Disease in Pregnancy.

Authors:  Lucy M Safi; Sarah V Tsiaras
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-09

6.  Adverse Pregnancy Conditions Among Privately Insured Women With and Without Congenital Heart Defects.

Authors:  Karrie F Downing; Naomi K Tepper; Regina M Simeone; Elizabeth C Ailes; Michelle Gurvitz; Sheree L Boulet; Margaret A Honein; Penelope P Howards; Anne M Valente; Sherry L Farr
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2020-06-08

Review 7.  Pregnancy Among Survivors of Childhood Cancer: Cardiovascular Considerations.

Authors:  Michael C Honigberg; Amy A Sarma
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-06-19

Review 8.  Pregnancy in adults with congenital heart disease.

Authors:  Elvin Zengin; Götz Mueller; Stefan Blankenberg; Yskert von Kodolitsch; Carsten Rickers; Christoph Sinning
Journal:  Cardiovasc Diagn Ther       Date:  2019-10

9.  Risk factors of postoperative acute kidney injury in patients with complex congenital heart disease and significance of early detection of serum transcription factor Nkx2.5.

Authors:  Haiyu Chen; Qiuqing Ke; Guoxing Weng; Jiayin Bao; Jie Huang; Licheng Yan; Fuzhen Zheng
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

10.  Clinical features and peripartum outcomes in pregnant women with cardiac disease: a nationwide retrospective cohort study in Japan.

Authors:  Toshiaki Isogai; Hiroki Matsui; Hiroyuki Tanaka; Akira Kohyama; Kiyohide Fushimi; Hideo Yasunaga
Journal:  Heart Vessels       Date:  2018-02-17       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.